Genetics may predict diabetes drug side-effects (1)

11 Jan 2019


Research, published in Cell Stem Cell, suggests that genetic variations in a patient’s fat cells can determine if the diabetes drug, rosiglitazone, will have unwanted side-effects.  

Science Daily


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story